Emergency Department Use of Heart Failure-Exacerbating Medications in Patients with Chronic Heart Failure.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1225, doi. 10.1007/s40264-024-01479-5
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2024 AND VI 47 AND IP 12
Results: 11
1
2
Acknowledgement to Referees.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1189, doi. 10.1007/s40264-024-01492-8
- Publication type:
- Article
3
Paracetamol Dosing Errors in People Aged 12 Years and Over: An Analysis of Over 14,000 Cases Reported to an Australian Poisons Information Centre.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1293, doi. 10.1007/s40264-024-01472-y
- By:
- Publication type:
- Article
4
23rd ISoP Annual Meeting "Global Perspectives on Pharmacovigilance in the Digital Age and Advanced Therapeutics" 1–5 October 2024 Montreal, Canada.
- Published in:
- 2024
- Publication type:
- Calendar
5
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1275, doi. 10.1007/s40264-024-01471-z
- By:
- Publication type:
- Article
6
A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1203, doi. 10.1007/s40264-024-01470-0
- By:
- Publication type:
- Article
7
Short-Term Training, a Useful Approach for Sustainable Pharmacovigilance Knowledge Development in Tanzania, Kenya, Ethiopia and Rwanda.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1193, doi. 10.1007/s40264-024-01469-7
- By:
- Publication type:
- Article
8
Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1245, doi. 10.1007/s40264-024-01467-9
- By:
- Publication type:
- Article
9
Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA Labeling.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1265, doi. 10.1007/s40264-024-01468-8
- By:
- Publication type:
- Article
10
A Calculated Risk: Evaluation of QTc Drug–Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1235, doi. 10.1007/s40264-024-01466-w
- By:
- Publication type:
- Article
11
RETRACTED ARTICLE: Long-Term Safety Analysis of the BBV152 Coronavirus Vaccine in Adolescents and Adults: Findings from a 1-Year Prospective Study in North India.
- Published in:
- Drug Safety, 2024, v. 47, n. 12, p. 1441, doi. 10.1007/s40264-024-01432-6
- By:
- Publication type:
- Article